user

Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline

被引：0
|
作者：
Kong, Hui [1 ]
Bai, Qianming [1 ]
Lu, Hongfen [1 ]
Zhou, Xiaoyan [1 ]
Yang, Wentao [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
185
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline
    Kong, Hui
    Bai, Qianming
    Lu, Hongfen
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2019, 99
  • [2] Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
    Hui Kong
    Qianming Bai
    Anqi Li
    Xiaoyan Zhou
    Wentao Yang
    Diagnostic Pathology, 17
  • [3] Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
    Kong, Hui
    Bai, Qianming
    Li, Anqi
    Zhou, Xiaoyan
    Yang, Wentao
    DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [4] HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline
    Yao-Shan Fan
    Carmen E. Casas
    Jinghong Peng
    Melanie Watkins
    Lynn Fan
    Jennifer Chapman
    Offiong Francis Ikpatt
    Carmen Gomez
    Wei Zhao
    Isildinha M. Reis
    Breast Cancer Research and Treatment, 2016, 155 : 457 - 462
  • [5] HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline
    Fan, Yao-Shan
    Casas, Carmen E.
    Peng, Jinghong
    Watkins, Melanie
    Fan, Lynn
    Chapman, Jennifer
    Ikpatt, Offiong Francis
    Gomez, Carmen
    Zhao, Wei
    Reis, Isildinha M.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 457 - 462
  • [6] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    LABORATORY INVESTIGATION, 2019, 99
  • [7] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    MODERN PATHOLOGY, 2019, 32
  • [8] HER2 targeted therapy and outcome in HER2equivocal cases after 2018 ASCO/CAP HER2 guideline modification
    Crespo, James
    Sun, Hongxia
    Wu, Jimin
    Ding, Qingqing
    Tang, Guilin
    Robinson, Melissa
    Chen, Hui
    Sahin, Aysegul A.
    Lim, Bora
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer
    Xu, Bin
    Shen, Jianguo
    Guo, Wenhao
    Zhao, Wenhe
    Zhuang, Yiyu
    Wang, Linbo
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (02) : 251 - 255
  • [10] Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
    Press, Michael F.
    Seoane, Jose A.
    Curtis, Christina
    Quinaux, Emmanuel
    Guzman, Roberta
    Sauter, Guido
    Eiermann, Wolfgang
    Mackey, John R.
    Robert, Nicholas
    Pienkowski, Tadeusz
    Crown, John
    Martin, Miguel
    Valero, Vicente
    Bee, Valerie
    Ma, Yanling
    Villalobos, Ivonne
    Slamon, Dennis J.
    JAMA ONCOLOGY, 2019, 5 (03) : 366 - 375
12345